Investors Cheer Revised, Better Than Expected iRhythm's FY22 Outlook
iRhythm Technologies Inc (NASDAQ:IRTC) posted Q1 sales of $92.4 million, up 24.3% Y/Y, beating the consensus of $86.76 million. The developer of remote external electrocardiogram monitors reported an adjusted EPS loss of $(0.80), above the consensus of $(1.08). “Our strong first-quarter results are indicative of the momentum we carried into 2022 with an…
Benzinga ·
Benzinga
